Skip to main content
Top
Published in: American Journal of Cardiovascular Drugs 4/2023

10-05-2023 | Supraventricular Tachycardia | Commentary

Adenosine Administration in Supraventricular Tachycardia: Single- or Double-Syringe Technique?

Authors: Marco Zuin, Gianluca Rigatelli

Published in: American Journal of Cardiovascular Drugs | Issue 4/2023

Login to get access

Excerpt

The term supraventricular tachycardia (SVT) indicates a heterogeneous group of arrhythmias generated by cardiac tissue at the His bundle or above [1]. A larger body of evidence has already demonstrated that SVT represents a common cause of hospitalization worldwide which increases both patient morbidity and mortality [2, 3]. In daily clinical practice, the most common forms of SVT are represented by atrioventricular nodal re-entrant tachycardia, atrioventricular re-entrant tachycardia and atrial tachycardia [4]. From an epidemiological perspective, previous analyses have estimated an SVT prevalence of about 2.25 per 1000 persons, with a female predominance of 2:1 [5]. Generally, we can identify two distinct subsets of patients with SVT: those with other concomitant cardiovascular disease and those with lone SVT [6]. …
Literature
1.
go back to reference Katritsis DG, Boriani G, Cosio FG, et al. European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Elect. Eur Heart J. 2018;39:1442–5.PubMed Katritsis DG, Boriani G, Cosio FG, et al. European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Elect. Eur Heart J. 2018;39:1442–5.PubMed
2.
go back to reference Kotadia ID, Williams SE, O’Neill M. Supraventricular tachycardia: an overview of diagnosis and management. Clin Med (Lond). 2020;20:43–7.CrossRefPubMed Kotadia ID, Williams SE, O’Neill M. Supraventricular tachycardia: an overview of diagnosis and management. Clin Med (Lond). 2020;20:43–7.CrossRefPubMed
3.
go back to reference Wang YS, Scheinman MM, Chien WW, et al. Patients with supraventricular tachycardia presenting with aborted sudden death: incidence, mechanism and long-term follow-up. J Am Coll Cardiol. 1991;18:1711–9.CrossRefPubMed Wang YS, Scheinman MM, Chien WW, et al. Patients with supraventricular tachycardia presenting with aborted sudden death: incidence, mechanism and long-term follow-up. J Am Coll Cardiol. 1991;18:1711–9.CrossRefPubMed
4.
go back to reference Lerman BB, Markowitz SM, Cheung JW, et al. Supraventricular tachycardia: mechanistic insights deduced from adenosine. Circ Arrhythm Electrophysiol. 2018;11: e006953.CrossRefPubMed Lerman BB, Markowitz SM, Cheung JW, et al. Supraventricular tachycardia: mechanistic insights deduced from adenosine. Circ Arrhythm Electrophysiol. 2018;11: e006953.CrossRefPubMed
5.
go back to reference Brugada J, Katritsis DG, Arbelo E, et al. ESC guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2019;2019:ehz467. Brugada J, Katritsis DG, Arbelo E, et al. ESC guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2019;2019:ehz467.
6.
go back to reference Orejarena LA, Vidaillet H Jr, DeStefano F, et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol. 1998;31:150–7.CrossRefPubMed Orejarena LA, Vidaillet H Jr, DeStefano F, et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol. 1998;31:150–7.CrossRefPubMed
7.
go back to reference Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the heart rhythm society. Circulation. 2016;133:e471-505.PubMed Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the heart rhythm society. Circulation. 2016;133:e471-505.PubMed
8.
9.
go back to reference McDowell M, Mokszycki R, Greenberg A. Single-syringe administration of diluted adenosine. Acad Emerg Med. 2020;27:61–3.CrossRefPubMed McDowell M, Mokszycki R, Greenberg A. Single-syringe administration of diluted adenosine. Acad Emerg Med. 2020;27:61–3.CrossRefPubMed
10.
go back to reference Choi S, Yoon S, Kim G, et al. A convenient method of adenosine administration for paroxysmal supraventricular tachycardia. J Korean Soc Emerg Med. 2023;14:224–7. Choi S, Yoon S, Kim G, et al. A convenient method of adenosine administration for paroxysmal supraventricular tachycardia. J Korean Soc Emerg Med. 2023;14:224–7.
11.
go back to reference Kotruchin P, Chaiyakhan IO, Kamonsri P, et al. Comparison between the double-syringe and the single-syringe techniques of adenosine administration for terminating supraventricular tachycardia: a pilot, randomized controlled trial. Clin Cardiol. 2022;45:583–9.CrossRefPubMedPubMedCentral Kotruchin P, Chaiyakhan IO, Kamonsri P, et al. Comparison between the double-syringe and the single-syringe techniques of adenosine administration for terminating supraventricular tachycardia: a pilot, randomized controlled trial. Clin Cardiol. 2022;45:583–9.CrossRefPubMedPubMedCentral
Metadata
Title
Adenosine Administration in Supraventricular Tachycardia: Single- or Double-Syringe Technique?
Authors
Marco Zuin
Gianluca Rigatelli
Publication date
10-05-2023
Publisher
Springer International Publishing
Published in
American Journal of Cardiovascular Drugs / Issue 4/2023
Print ISSN: 1175-3277
Electronic ISSN: 1179-187X
DOI
https://doi.org/10.1007/s40256-023-00584-7

Other articles of this Issue 4/2023

American Journal of Cardiovascular Drugs 4/2023 Go to the issue